CBAI Cord Blood America Inc. featured news, full reports, and detailed charts
Cord Blood America Inc. (CBAI/CBAI.OB) Wrap Up:
Cord Blood America, Inc., through its subsidiaries, provides private cord blood stem cell preservation services to families in the Untied States. The company also engages in the collection, testing, processing, and preservation of peripheral blood and adipose tissue stem cells, which allows individuals to privately preserve their stem cells for potential future use in stem cell therapy. In addition, it engages in the collection, transportation, testing, and preservation of umbilical cord blood. Further, the company engages in the advertising operations, including procuring and placing radio and television advertising; per-inquiry advertising on radio and television; producing radio and telev...Cord Blood America Inc. (CBAI:OTC Bulletin Board Market)
Snapshot of Cord Blood America Inc. (CBAI)
|
OPEN
--
|
PREVIOUS CLOSE
$0.0052
|
|
|
DAY HIGH
--
|
DAY LOW
--
|
|
|
52 WEEK HIGH
01/29/09 - $0.03
|
52 WEEK LOW
12/31/08 - $0.0011
|
|
|
MARKET CAP
23.8M
|
AVERAGE VOLUME 3 mo
39.4M
|
|
|
DILUTED EPS TTM
$-0.0073
|
SHARES OUTSTANDING
4.6B
|
|
|
CBAI Does Not Pay Dividends
|
P/E TTM
NM
|
|
| K = Thousands M = Millions B = Billions | ||
CBAI Top Compensated Officers
Executives, Board Directors
Key developments for Cord Blood America Inc. (CBAI)
Cord Blood America Inc. reported revenue results for the third quarter and nine months ended September 30, 2009. For the quarter, the company's revenue decrease to $838,238 in the third quarter of 2009 compared to $927,359 in the same period in 2008. For the nine months ended September 30, 2009, the company's revenue decrease to $2.6 million compared to $3.3 million in the same period in 2008. A decrease in revenues is attributable to a de-emphasis on the advertising business coupled with difficult economic conditions.
Cord Blood America Inc. announced that it has retired three more significant debts with originally issued principal amounts of $212,959, $250,000 and $285,000. The $212,959 and $250,000 notes were signed in 2007 with CorCell Inc., which became Cord Blood America's operating unit, CorCell Companies Inc., and were purchased by JMJ Financial. The $285,000 note was originally signed in August 2006 with Strategic Working Capital and subsequently purchased by JMJ Financial. All three notes were retired by September 30, 2009.
Cord Blood America Inc. announced that it has retired a note, principal amount $160,000, in its continuing effort to reduce debt. Cord Blood America previously announced that, through August of 2009, it had reduced its secured debt by $6.6 million.
CBAI Competitors
| Company | Last | Change |
| Cryo-Cell Intl Inc | $1.84 USD | -0.09 |
| International Stem Cell Corp | $0.62 USD | -0.02 |
| Stem Cell Therapy International Inc | $0.14 USD | +0.001 |
| Market data is delayed at least 20 minutes. | ||
Industry Analysis
| Valuation | CBAI | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | 2.5x |
|
| Price/Book | NM | Not Meaningful |
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | 5.8x |
|
|
CBAI |
||
CBAI transactions
| Type Date |
Target |
|
Private Placement
July 2, 2009 |
-- |
|
Private Placement
June 23, 2009 |
-- |
